Functional analysis of the two cytidine deaminase domains in APOBEC3G (Q28235487)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Functional analysis of the two cytidine deaminase domains in APOBEC3G (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Xiaoyu Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Jing Ma

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Quan Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Jinming Zhou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Xiao Yin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Congjie Zhai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Xuefu You

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Liyan Yu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Lixun Zhao

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Zelin Li

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Yi Zeng

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Shan Cen

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

language of work or name

English

0 references

publication date

13 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

130-136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489586%20AND%20SRC:MED&resulttype=core&format=json

Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

APOBEC3G inhibits elongation of HIV-1 reverse transcripts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

The interaction between HIV-1 Gag and APOBEC3G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Human cytidine deaminase APOBEC3H restricts HIV-1 replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

The sor gene of HIV-1 is required for efficient virus transmission in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Retroviral restriction by APOBEC proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Role of RNA in facilitating Gag/Gag-Pol interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

A portable hot spot recognition loop transfers sequence preferences from APOBEC family members to activation-induced cytidine deaminase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Complementary function of the two catalytic domains of APOBEC3G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Dissecting APOBEC3G substrate specificity by nucleoside analog interference.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Evidence for a newly discovered cellular anti-HIV-1 phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

The HIV 'A' (sor) gene product is essential for virus infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Interaction with 7SL RNA but not with HIV-1 genomic RNA or P bodies is required for APOBEC3F virion packaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

APOBEC3G incorporation into human immunodeficiency virus type 1 particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Rapid evolution of primate antiviral enzyme APOBEC3G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Model structure of human APOBEC3G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Function analysis of sequences in human APOBEC3G involved in Vif-mediated degradation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Association of Potent Human Antiviral Cytidine Deaminases with 7SL RNA and Viral RNP in HIV-1 Virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014

Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.014